The Narrative on Trial

  Fiona Rose Diamond began reporting on this case at the decisive procedural hearing (of global importance) at the Amsterdam Court of Appeal on 9th March 2026. This hearing formed part of wider Covid litigation now unfolding in the Netherlands: The "Leeuwarden Litigation." 

The civil action, brought against Big Pharma, state actors and institutions—including Bill Gates, Pfizer CEO Albert Bourla, former Dutch PM, state authorities and media organisations—alleges that a sustained campaign of propaganda and misinformation led claimants to accept mRNA Covid injections, through fear and coercion, that caused profound harm. 

On 9th March, the Court of Appeal was asked to decide whether to allow an appeal against an earlier refusal to hold a preliminary evidence hearing—a process that would enable expert witnesses to be questioned under oath and key scientific and factual claims to be tested before the full civil (Leeuwarden Litigation) case proceeds.

The Leeuwarden Litigation (wider lawsuit) began in the summer of 2023, when seven Dutch citizens who were injured by Pfizer Covid injections filed a civil claim in the Leeuwarden District Court. They argue that government officials, public health authorities, pharmaceutical executives and media figures misled the public about the nature of the Covid threat and the safety and necessity of ‘vaccination.’ They assert this misinformation and propaganda created fear and compliance, leading them to take the injections and suffer physical or psychological harm. They are asking the court to declare the defendants acted unlawfully and to award damages.

The separate preliminary evidence case—filed in March 2025 by three separate injured petitioners—was intended to strengthen the primary lawsuit by securing expert testimony and testing contested evidence in advance. Although the lower court refused that request, the appeal hearing represents an attempt to reopen the door to that process. Regardless of the outcome, the main civil trial involving the seven injured claimants will still proceed, but the decision on this appeal could determine whether expert evidence is examined early, prior to the full trial.

I travelled to Amsterdam to bear witness to this hearing and to help bring international attention to what is unfolding in the Dutch courts. Since then, I have worked intensively to translate documents, compile case materials and provide clear coverage so that others can understand both the legal issues and the wider significance of this litigation.

If you value this work and wish to support continued reporting from future hearings, you can contribute using the link below. As an independent campaigner and law student operating without funding or salary, your support directly enables this coverage to continue.

 I’ll be covering this case from start to finish. Every development, every hearing, every turning point. All of my reporting—articles and exclusive video coverage—will be published on Substack.

Click the button below to follow the case as it unfolds.